Skip to main content
. 2022 May 12;23:121. doi: 10.1186/s12931-022-02029-2

Table 3.

Cold-induced symptoms during each trial

30 min 90 min
Symptom Before After  + 20 min Before After  + 20 min
Nasal irritation 0.25 (0–1) 2 (0.25–2)** 0 (0–1) 0.25 (0–1) 2 (0.875–3)** 0.5 (0–1)
Nasal mucus 1 (0.375–2.25) 4 (3–5)*** 1 (0.5–2) 1 (0.75–2) 5 (4–6.25)*** 0.75 (0.375–2)
Cold face 0 (0–0) 3 (2–4.5)*** 0 (0–0.625)* 0 (0–0) 3.5 (3–6)*** 0.25 (0–1)*
Cold extremities 0 (0–0.6) 3 (0–4.5)** 0.5 (0–1) 0 (0–0.875) 3.5 (1.75–6.5)** 1.25 (0–3)
Physical discomfort 0 (0–0.5) 2 (0–3)** 0 (0–0.5) 0 (0–0.5) 2.5 (0.5–4)** 0.5 (0–2)
Shortness of breath 0 (0–0.5) 2 (1–2)** 0 (0–1) 0 (0.25–0.5) 2 (1–3)*** 0.25 (0–0.5)
Warm in body 1.5 (0–3) 3 (0.75–4) 1 (0.5–3) 2 (0.5–3) 4 (2–5)** 3 (1.25–3.5)
Irritation in the chest 0 (0–0.5) 0 (0–2) 0.25 (0–1) 0 (0–1) 1.25 (0–2)** 0.5 (0–2)
Irritation in the mouth and throat 1 (0.375–2.25) 4 (3–5) 1 (0–2) 1 (0.75–2) 5 (4–6.25)** 1 (0–2.25)

Data are presented as median (IQR). Significant difference within trial, compared to baseline (*, p < 0.05, **, p < 0.01; ***, p < 0.001); Significant difference between trials (p < 0.05)